Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02801877 · ClinicalTrials.gov registry record · NA
IntelliCare Study: Artificial Intelligence in a Mobile (AIM) Intervention for Depression
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 301
- Enrollment target
NCT02801877: Completed NA study, sponsored by Northwestern University.
NCT02801877 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 301 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02801877, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 301 participants
- Enrollment target
Study Summary
This study will evaluate and compare a smartphone intervention for depression and anxiety that uses machine learning to tailor treatment for participants with the same intervention without the machine learning component. The intervention, referred to as IntelliCare, delivers participant-specific treatment material and motivational messaging via a mobile phone to help individuals with depression and/or anxiety. Information and data received from the participant will inform the tailored treatment approach through machine learning. The purpose of this study is to compare different versions of the main IntelliCare Hub App (the centralized program delivery system) and participant user experience whether with the support of a coach or used independently. The randomized clinical trial (RCT) aims to obtain information on the feasibility and effectiveness of IntelliCare in improving symptoms of depression and anxiety.
Primary Outcome
Defined as the median time to last engagement with the mobile application suite within 8 weeks of trial
Interventions
- BEHAVIORAL IntelliCare
- BEHAVIORAL Coaching
- BEHAVIORAL Hub App with the Recommender System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 301 participants |
| Start Date | 2016-07 |
| Est. Completion | 2018-01 |
| Phase | NA |
What the finished NCT02801877 record still lists
NCT02801877 is an interventional study that assigns participants to a tested intervention. The registered 301 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 3 interventions - of which IntelliCare is the first listed.
NCT02801877 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02801877 about?
NCT02801877 is a clinical study titled "IntelliCare Study: Artificial Intelligence in a Mobile (AIM) Intervention for Depression". This study will evaluate and compare a smartphone intervention for depression and anxiety that uses machine learning to tailor treatment for participants with the same intervention without the machine learning component. The intervention, referred to as IntelliCare, delivers participant-specific tre...
What is the current status of trial NCT02801877?
This trial is currently completed. It is a NA study. The enrollment target is 301 participants. The study started on 2016-07. Estimated completion is 2018-01.
What interventions are being tested in trial NCT02801877?
The interventions under investigation include: IntelliCare (BEHAVIORAL), Coaching (BEHAVIORAL), Hub App with the Recommender System (BEHAVIORAL).
Who is sponsoring clinical trial NCT02801877?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02801877's enrollment target sits among peer trials
301 330th of 2000 higher than 1,671 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05005975 · 301 participants · Phase 3
Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)
- NCT05722561 · 302 participants · Phase 2
E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder
- NCT06015737 · 302 participants · Phase 3
A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus
- NCT07176273 · 302 participants · NA
Adaptive Decision-making And Personalized Treatment for PTSD (ADAPT-PTSD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia